XBiotech Inc.

09/02/2025 | Press release | Distributed by Public on 09/02/2025 11:10

Proxy Results (Form 8-K)

Item 5.07 Submission of Matters to a Vote of Security Holders.

The annual meeting of the stockholders of XBiotech Inc. (the "Company") was held on August 29, 2025. The matters that were voted upon at the meeting, and the number of votes cast for and against, as well as the number of abstentions and broker non-votes as to each such matter, are set forth below. Stockholders voted in accordance with the Board of Directors' recommendations on each matter and voted to (1) elect five nominees for director; (2) ratify the selection by the Audit Committee of the Board of Directors of Whitley Penn LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025;(3)approve, on an advisory basis, the compensation of the Company's named executive officers;(4) approve the Company's 2025 Equity Incentive Plan.

Proposal #1Election of five members of the Board of Directors

For Abstain Broker Non-Votes
John Simard 12,371,115 494,017 2,824,207
Thomas Kündig 12,698,614 166,518 2,824,207
Craig Rademaker 12,501,468 363,664 2,824,207
Tevi D. Troy 12,301,285 563,847 2,824,207
David Soffer 12,302,090 563,042 2,824,207

Proposal #2Ratification of the selection of Whitley Penn LLP as the Company's independent registered public accounting firm for the fiscal year ending 2025

For Against Abstain Broker Non-Votes
15,206,712 413,673 68,954 0

Proposal #3Advisory Vote on Executive Compensation

For Against Abstain Broker Non-Votes
11,336,500 1,460,498 68,134 2,824,207

Proposal #4Approval of the Company's 2025 Equity Incentive Plan

For Against Abstain Broker Non-Votes
11,952,280 904,108 8,744 2,824,207
XBiotech Inc. published this content on September 02, 2025, and is solely responsible for the information contained herein. Distributed via SEC EDGAR on September 02, 2025 at 17:10 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]